Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AN2 Therapeutics, Inc. - Common Stock (NQ: ANTX )

9.870 +0.240 (+2.49%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 25,484
Open 9.630
Bid (Size) 9.000 (1)
Ask (Size) 15.79 (2)
Prev. Close 9.630
Today's Range 9.130 - 9.980
52wk Range 6.879 - 23.58
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AN2 Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
From AN2 Therapeutics, Inc.
Via Business Wire
AN2 Therapeutics to Participate in Upcoming Investor Conferences
From AN2 Therapeutics, Inc.
Via Business Wire

Performance

YTD
+1.54%
+1.54%
1 Month
-13.42%
-13.42%
3 Month
+3.57%
+3.57%
6 Month
-43.21%
-43.21%
1 Year
-34.51%
-34.51%

More News

Read More
AN2 Therapeutics to Present at SVB Securities Global Biopharma Conference
From AN2 Therapeutics, Inc.
Via Business Wire
Top 5 Health Care Stocks That May Dip
Via Benzinga
Lennar To Rally Around 14%? Plus Keybanc Predicts $5,120 For This Stock
Via Benzinga
AN2 Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
From AN2 Therapeutics, Inc.
Via Globe NewsWire
AN2 Therapeutics to Present at Upcoming Investor Conferences
From AN2 Therapeutics, Inc.
Via Globe NewsWire
AN2 Therapeutics to Present New Epetraborole Data at IDWeek 2022
From AN2 Therapeutics, Inc.
Via Globe NewsWire
Uber, Lyft, AZZ And Other Big Losers From Tuesday
Via Benzinga
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
Via Benzinga
AN2 Therapeutics Provides Update on Epetraborole Ex-U.S. Development Plan in Treatment-Refractory MAC Lung Disease
From AN2 Therapeutics, Inc.
Via Globe NewsWire
NIH Awards Contract to AN2 Therapeutics Valued Up to $17.8 Million
From AN2 Therapeutics, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
Via Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Via Benzinga
Nasdaq Drops 200 Points; American Woodmark Shares Spike Higher
Via Benzinga
How Is The Market Feeling About AN2 Therapeutics?
Via Benzinga
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
Via Benzinga
LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.